Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
245.73
-3.03 (-1.22%)
At close: May 9, 2025, 4:00 PM
248.36
+2.63 (1.07%)
After-hours: May 9, 2025, 7:35 PM EDT
Labcorp Holdings Revenue
Labcorp Holdings had revenue of $3.35B in the quarter ending March 31, 2025, with 5.30% growth. This brings the company's revenue in the last twelve months to $13.18B, up 7.13% year-over-year. In the year 2024, Labcorp Holdings had annual revenue of $13.01B with 6.97% growth.
Revenue (ttm)
$13.18B
Revenue Growth
+7.13%
P/S Ratio
1.56
Revenue / Employee
$188,249
Employees
70,000
Market Cap
20.57B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
Dec 31, 2022 | 11.86B | -1.27B | -9.68% |
Dec 31, 2021 | 13.14B | -842.40M | -6.03% |
Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
LH News
- 2 days ago - Labcorp to Webcast Its Annual Meeting of Shareholders May 15 - PRNewsWire
- 11 days ago - Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Labcorp beats quarterly profit estimate on diagnostic test demand - Reuters
- 12 days ago - Labcorp Announces 2025 First Quarter Results - PRNewsWire
- 18 days ago - Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions - PRNewsWire
- 4 weeks ago - Genetic Screening Testing for the Preventive Health Market, 2025-2035 Analysis - Dominated by Exact Science, Labcorp Genetics, Blueprint Genetics, Ambry Genetics, and Genex Diagnostics - GlobeNewsWire
- 4 weeks ago - Labcorp Declares Quarterly Dividend - PRNewsWire
- 5 weeks ago - Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease - PRNewsWire